News

  • Overview
  • Regulatory News

Latest webfg news

Berenberg upgrades GSK to 'buy', raises target price 15 Sep
GSK acquires global rights to multiple myeloma asset from Chimagen Biosciences 15 Sep
GSK highlights pipeline momentum with Ris‑Rez phase III success, Jideytro first‑line efficacy 14 Sep
GSK gets Japanese approval for new ready‑to‑use shingles vaccine format 10 Sep
GSK advances mRNA flu shot after Phase II success 01 Sep
GSK notches major regulatory milestones in Japan and US 24 Aug
GSK launches £2bn cost savings drive, confirms new Cambridge hub 28 Jul
GSK secures EMA review for single‑dose Bexsero booster 20 Jul
GSK shares fall as cough drug development axed 17 Jul
GSK rectal cancer drug shows positive result in key trial 13 Jul
GSK hails 'milestone' drug trial results in China 10 Jul
GSK's momelotinib receives orphan drug designation from US and EU watchdogs 12 Jun
GSK to buy Boston-based biopharma firm Nuvalent for $10.6bn 09 Jun
Trials show GSK drug cures hepatitis B in nearly 20% of patients 28 May
Citi sees buying opportunity at AstraZeneca after recent falls 18 May
GSK strikes agreement with China's SBP Group, launches final tranche of buyback programme 11 May
Sales jump at GSK on strong demand for specialty drugs 29 Apr
GSK hepatitis B drug secures FDA priority review 28 Apr
US court rules against GSK in dispute with AnaptysBio 27 Apr
GSK's Blenrep gets green light from China's NMPA 20 Apr
  • «
  • 2026-05
  • 2026-06
  • 2026-07
  • 2026-08
  • 2026-09
Advertising
Advertising